Issues of trust, and a matter of time as South Africa begin vaccination of poultry
Image: File picture
By Thabile Nkunjana
On July 1st, 2025, the Department of Agriculture declared that the government would be starting its first-ever poultry industry vaccination program against highly pathogenic avian influenza (HPAI).
Astral, one of South Africa's top chicken producers, has been granted permission to start its virus immunisation program. As a first phase, only a small portion of Astral's stock—roughly 5% of the total—will be vaccinated.
According to data from the World Organisation for Animal Health (OAH), we are approaching the months when outbreaks often occur, thus the poultry sector has embraced this decision.
The industry had recovered from the broiler side of things following the 2023 virus outbreak that caused a 30% reduction in industry flock and cost at least R9 billion, but the egg side is still recovering. Given that the virus outbreak is approaching its peak in terms of outbreaks, the poultry sector has applauded the move to vaccinate.
However, even while the industry is pleased with the decision, many people are highly sceptical about it, and many have expressed their concerns on social media, including in a post by the agriculture minister. The primary concern is if eating items from a vaccinated bird is safe. The possibility that vaccination use could lead to mutations and resistance to the doses has also been raised on multiple occasions.
Many countries around the world have already started utilising avian influenza vaccines after their poultry industries suffered severe economic setbacks and threatening livelihoods.
Since 2005, vaccination against avian influenza has been used to prevent the infection in more than 30 countries globally. These include, among others, China, the world's largest egg producer, Mexico and Egypt to name some.
Following the severity of the virus, which had a major impact on many countries in Europe like France, the European Union (EU-27), which is made up of 27 countries, started vaccination program in May 2023.
It's also crucial to remember that a number of countries have yet to use the vaccines on poultry. These include the United States of America, the world's top exporter of live birds and a leading poultry producer, Brazil, the world's top exporter of poultry, and the United Kingdom.
But according to recent reports, the United States is considering of implementing a vaccination program in response to the ongoing avian influenza outbreak there. There is reportedly a plan in place for possible utilisation. Additionally, Brazil has not been vaccinating because the viral outbreak there did not occur until lately. However, Brazil's agriculture minister has called for the discussion of vaccinations, which is a big step considering the Brazilians' prior concerns about this.
As was previously noted, Brazil is the greatest poultry exporter in the world, and since they are afraid of trade limitations, they have been suspicious of vaccination in their poultry. However, they could as well end up vaccinating given the recent outbreak in Brazil.
Especially in endemic and recently impacted areas, vaccination is an essential technique for reducing the impact and spread of infectious illnesses. Additionally, several countries throughout the world have previously implemented the vaccination that South Africa is starting for the past 19 years, and no proof has been offered about the risk or illnesses associated with consumption of vaccinated poultry.
Also, vaccination is used to prevent diseases like rift valley fever, clostridial disease, and lumpy valley fever in cattle. Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated illness (PCVAD), Aujeszky's illness (Pseudorabies), and Classical Swine Fever are all prevented or controlled via vaccination programs for pigs.
Meat and other products from animals, including beef and pork, are ingested because they are considered safe to eat and there are no reasons yet to doubt poultry consumption because of vaccination.
It is fair to be concerned about immunisations. South Africa is part of a global trend towards greater consumer consciousness. Consumers are paying more attention to the origins of their food, the ingredients utilised in its production, and its manufacturing process.
Research on poultry specifically indicates that roughly 30% of consumers in developed countries are willing to purchase this type of meat. However, the cost is a problem because this type of meat is typically pricey and is not produced to the scale other commercial poultry production is.
Thabile Nkunjana is a senior economist under the Trade Research Unit at the National Agricultural Marketing Council.
Image: LinkedIn
* Thabile Nkunjana is a senior economist under the Trade Research Unit at the National Agricultural Marketing Council.
** He writes on his personal capacity, and does not, necessarily express of IOL or Independent Media.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

IOL News
a day ago
- IOL News
Issues of trust, and a matter of time as South Africa begin vaccination of poultry
Astral, one of South Africa's top chicken producers, has been granted permission to start its virus immunisation program. As a first phase, only a small portion of Astral's stock—roughly 5% of the total—will be vaccinated. Image: File picture By Thabile Nkunjana On July 1st, 2025, the Department of Agriculture declared that the government would be starting its first-ever poultry industry vaccination program against highly pathogenic avian influenza (HPAI). Astral, one of South Africa's top chicken producers, has been granted permission to start its virus immunisation program. As a first phase, only a small portion of Astral's stock—roughly 5% of the total—will be vaccinated. According to data from the World Organisation for Animal Health (OAH), we are approaching the months when outbreaks often occur, thus the poultry sector has embraced this decision. The industry had recovered from the broiler side of things following the 2023 virus outbreak that caused a 30% reduction in industry flock and cost at least R9 billion, but the egg side is still recovering. Given that the virus outbreak is approaching its peak in terms of outbreaks, the poultry sector has applauded the move to vaccinate. However, even while the industry is pleased with the decision, many people are highly sceptical about it, and many have expressed their concerns on social media, including in a post by the agriculture minister. The primary concern is if eating items from a vaccinated bird is safe. The possibility that vaccination use could lead to mutations and resistance to the doses has also been raised on multiple occasions. Many countries around the world have already started utilising avian influenza vaccines after their poultry industries suffered severe economic setbacks and threatening livelihoods. Since 2005, vaccination against avian influenza has been used to prevent the infection in more than 30 countries globally. These include, among others, China, the world's largest egg producer, Mexico and Egypt to name some. Following the severity of the virus, which had a major impact on many countries in Europe like France, the European Union (EU-27), which is made up of 27 countries, started vaccination program in May 2023. It's also crucial to remember that a number of countries have yet to use the vaccines on poultry. These include the United States of America, the world's top exporter of live birds and a leading poultry producer, Brazil, the world's top exporter of poultry, and the United Kingdom. But according to recent reports, the United States is considering of implementing a vaccination program in response to the ongoing avian influenza outbreak there. There is reportedly a plan in place for possible utilisation. Additionally, Brazil has not been vaccinating because the viral outbreak there did not occur until lately. However, Brazil's agriculture minister has called for the discussion of vaccinations, which is a big step considering the Brazilians' prior concerns about this. As was previously noted, Brazil is the greatest poultry exporter in the world, and since they are afraid of trade limitations, they have been suspicious of vaccination in their poultry. However, they could as well end up vaccinating given the recent outbreak in Brazil. Especially in endemic and recently impacted areas, vaccination is an essential technique for reducing the impact and spread of infectious illnesses. Additionally, several countries throughout the world have previously implemented the vaccination that South Africa is starting for the past 19 years, and no proof has been offered about the risk or illnesses associated with consumption of vaccinated poultry. Also, vaccination is used to prevent diseases like rift valley fever, clostridial disease, and lumpy valley fever in cattle. Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated illness (PCVAD), Aujeszky's illness (Pseudorabies), and Classical Swine Fever are all prevented or controlled via vaccination programs for pigs. Meat and other products from animals, including beef and pork, are ingested because they are considered safe to eat and there are no reasons yet to doubt poultry consumption because of vaccination. It is fair to be concerned about immunisations. South Africa is part of a global trend towards greater consumer consciousness. Consumers are paying more attention to the origins of their food, the ingredients utilised in its production, and its manufacturing process. Research on poultry specifically indicates that roughly 30% of consumers in developed countries are willing to purchase this type of meat. However, the cost is a problem because this type of meat is typically pricey and is not produced to the scale other commercial poultry production is. Thabile Nkunjana is a senior economist under the Trade Research Unit at the National Agricultural Marketing Council. Image: LinkedIn * Thabile Nkunjana is a senior economist under the Trade Research Unit at the National Agricultural Marketing Council. ** He writes on his personal capacity, and does not, necessarily express of IOL or Independent Media.


The Citizen
a day ago
- The Citizen
AHF launches Demonstration Garden to support HIV patients
The AIDS Healthcare Foundation (AHF) recently launched its Demonstration Garden at Klarinet Community Health Centre (CHC) to support food security for people living with HIV. On June 12, the AHF gathered the community together to introduce to them the garden that will benefit participants and support Klarinet CHC patients, also addressing food security for people living with HIV. 'As AHF, we are committed to providing prevention, treatment, and care services for people living with HIV,' said Dr Maxime Molisho, AHF Mpumalanga Provincial Medical Manager. Dr. Molisho explained the disease in depth, sharing that it weakens the immune system, making individuals more vulnerable to infections. He further shared that factors such as illness, stress, and social conditions can compromise immunity, even before the progression to AIDS. 'Additionally, food insecurity and malnutrition, whether due to lack of access, poor absorption, or inadequate nutritional intake, can exacerbate HIV and hasten its progression,' he added. The community was thrilled with all the information and skills they learnt from the organisation and the officials from the Department of Agriculture, who shared hands-on instruction on growing cost-effective, high-yield crops to improve food security for them and their families. AHF commended all the various departments and stakeholders who contributed to the success of the launch, further extending gratitude to the community members for the enthusiasm and commitment they shown towards the initiative. Breaking news at your fingertips … Follow WITBANK NEWS on our website, Facebook, Twitter, Instagram or TikTok Chat to us: [email protected] At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!

IOL News
a day ago
- IOL News
Strengthening pandemic readiness: South Africa's collaboration with Germany and the EU
This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses. Image: File South Africa is reinforcing its leadership role in global pandemic preparedness through a major expansion of its genomic surveillance partnership with Germany and the European Union. The next phase of the Genomic Surveillance Project was officially launched on 24 June at the Centre for Epidemic Response and Innovation (CERI), Stellenbosch University's premier epidemic response institute based at its Tygerberg campus. The project is a collaboration between CERI and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), under the broader SAVax Programme. SAVax is co-funded by Germany's Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), and is implemented in partnership with South Africa's Department of Health and Department of Science, Technology and Innovation. The new phase brings an additional R9 million in funding, bringing the total investment in the project to R12 million. This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses. 'South Africa is uniquely positioned to play this role,' said Katja Fuehrer, Specialist for Monitoring and Evaluation, Communication, and Commission Management at GIZ. 'The country has a strong industrial base, a highly skilled workforce, and some of the world's leading research institutions. With SAVax, we are tapping into those strengths to bolster Africa's ability to respond to future pandemics more independently and effectively.' The first phase of the project, which ran from 2023 to 2024, sequenced over 1,000 pathogen genomes, trained more than 50 African scientists, and improved data-sharing protocols to support more effective outbreak responses. The new phase aims to scale these efforts even further by expanding genomic surveillance of respiratory pathogens, strengthening lab capacity in under-resourced provinces, and investing in the training of scientists at historically disadvantaged institutions in South Africa. Establishing robust systems to monitor and analyse genetic information from pathogens helps South Africa to quickly detect and track changes in viruses proactively. This allows for faster responses to outbreaks and enhances pandemic preparedness in the country and the entire region. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Ad loading The launch event at CERI featured a tour of laboratories, a panel discussion, and a grant award ceremony attended by senior officials and diplomats. 'We are delighted to expand the collaboration with South Africa,' said Fulgencio Garrido Ruiz, EU Deputy Ambassador to South Africa. 'There is one aspect at the core of the approach which is research and development. A robust local research framework that enhances self-sufficiency and empowers nations to respond independently to health crisis.' To date, the Team Europe Initiative MAV+ has mobilised more than 700 million euro's in South Africa, with 10 million euro's allocated to research infrastructure alone. Sven Hartwig, Deputy Consul General at the German Consulate General in Cape Town, echoed this sentiment. 'It is an honour for the German cooperation to contribute to the Team Europe Initiative MAV+ and to work alongside dedicated partners like CERI,' he said. 'This launch highlights that surveillance for pandemic preparedness relies on partnership and collaboration between the public and private sectors, academia, and civil society. Germany is therefore particularly proud to continue supporting genomic surveillance and remains steadfast in its commitment to share global health goals.' The launch event at the CERI Headquarters on Stellenbosch University's Tygerberg Campus included a tour of laboratories, a panel discussion and a grant award ceremony attended by senior officials and dignitaries. Image: Stellenbosch University Dr Anban Pillay, Deputy Director General from the National Department of Health, emphasised the local value of the initiative. 'The work of CERI and the University of Stellenbosch foster a culture of collaboration.' Claudia Aguirre, head of the GIZ SAVax programme, underlined the importance of capacity building in this next phase of the partnership. 'In this new collaboration these capacity building efforts will be expanded. We look forward to supporting CERI in its journey to develop science on the African continent and contribute to the development of solutions by African scientists for Africa.' The broader SAVax programme also aligns with the African Union's ambitious target to locally produce 60% of the continent's vaccines by 2040. By strengthening surveillance, vaccine development, and training programmes, the partnership aims to reduce Africa's dependency on imported vaccines and diagnostics. 'This partnership exemplifies how science, government, and international cooperation can come together to strengthen public health systems and respond more effectively to epidemic threats,' said Professor Tulio de Oliveira, Director of CERI. 'This is especially important for respiratory pathogens and new pathogens like Mpox, which have pandemic potential. The economic cost of a pandemic is so large that preventing it is a very wise and cost-effective investment.' Fuehrer added that South Africa is now one of only two countries in the Southern Hemisphere conducting real-time genomic tracking of respiratory pathogens, a development that not only strengthens national capacity but fills critical global gaps. 'The data generated in South Africa is shared publicly through international databases, enabling the global health community to monitor pathogens, identify emerging threats, and refine pandemic preparedness,' said Fuehrer. 'It's about shifting the centre of gravity in global health — bringing Africa to the table not just as a recipient, but as a producer, a leader, and a partner.'